There is an unmet need for integrating quantitative imaging biomarkers into current risk stratification tools. To explore the correlation between radiomics features –alone or in combintaion with clinical prognosticators- and tumor outcome, we retrieved clinical meta-data and matched baseline contrast-enhanced computed tomography (CECT) scans from a single institution, institutional review board (IRB)-approved cohort of 495 oropharyngeal cancer (OPC) patients. We opted to publicly share this large curated data set and subsequent radiomics analytical outcome via The Cancer Imaging Archive (TCIA) to serve as a resource for optimized standardization in the radiomics field.
|